Literature DB >> 2323890

BOP reagent for the coupling of pGlu and Boc-His(Tos) in solid phase peptide synthesis.

M Forest1, A Fournier.   

Abstract

The model peptide TRH was successfully synthesized using benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP reagent). The coupling reactions were carried out in N,N-dimethylformamide or N-methylpyrrolidone. These solvents allowed the incorporation of the N-terminal pyroglutamic acid residue into the peptide chain, without using the derivative bearing the N-benzyloxycarbonyl group, which acts as a solubility promoter. A comparative racemization study showed that Boc-His(Tos) can be coupled by means of BOP reagent with less racemization than with DCC when the amount of diisopropylethylamine (DIEA) is kept minimal (same ratio of equivalents as for Boc-His(Tos), i.e. 3 equiv.). However, with the use of a larger amount of DIEA in the coupling mixture (9 equiv.), approximately 3% of epimer was found in the crude product. Our study showed that even under low DIEA conditions, the rate of coupling of the residues with BOP remained comparable to that observed with DCC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323890     DOI: 10.1111/j.1399-3011.1990.tb00240.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  3 in total

1.  Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor.

Authors:  W F Colmers; G J Klapstein; A Fournier; S St-Pierre; K A Treherne
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor.

Authors:  D Bleakman; W F Colmers; A Fournier; R J Miller
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

3.  Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides.

Authors:  M W Yu; J K Scott; A Fournier; P J Talbot
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.